Page 2 - Jay Lichter News Today

Avalon BioVentures unveiled new portfolio company Arialys Therapeutics. The startup’s lead program, an antibody from Astellas Pharma, is a potential treatment for anti-NMDA receptor encephalitis (ANRE), a rare autoimmune inflammatory disorder.

FOR46, an ADC targeting CD46, is in Phase 1 development with potential applications in mCRPC and other CD46-expressing cancersCollaboration expands FibroGen’s clinical pipeline with potential... | May 8, 2023

--

Founded in 2008, Otonomy worked on a variety of treatments for ear diseases but suffered setbacks in recent clinical trials

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

The biotech team at Avalon Ventures has spun out into a new venture capital organization focused solely on backing early stage life science firms

Avelas makes senior appointments and provides update on pegloprastide Phase III clinical program Ambareen Sheriff appointed as Vice President, Regulatory and Quality and Robin Stevens appointed

Olympus broadens endoscopy spectrum with Quest acquisition 02 Feb 2021 Industrial and medical imaging company Olympus is set to broaden the capability of its endoscopy offering significantly, with the acquisition of Netherlands-headquartered Quest Photonic Devices. Established back in 1998 as Quest Innovations, the Middenmeer-based company specializes in fluorescence and multispectral techniques for applications including better visualization of tumor margins during cancer surgery. Tokyo-base...